Emory faculty members join prestigious ASCI
Woodruff Health Sciences Center | April 24, 2014
Three Emory University School of Medicine (SOM) faculty members were honored on April 25 with election into the American Society for Clinical Investigation (ASCI).
The ASCI is one of the nation’s oldest and most respected medical honor societies for physician-scientists, those who translate findings in the laboratory to the advancement of clinical practice.
The Emory SOM selectees are: Daniel J. Brat, MD, PhD, professor of pathology and laboratory medicine, Craig M. Coopersmith, MD, professor of surgery, and Young-sup Yoon, MD, PhD, professor of cardiology. They join more than 3,000 members from all medical specialties elected to ASCI for their outstanding records of scholarly achievement in biomedical research.
“It is an honor to have multiple Emory faculty members joining the distinguished American Society for Clinical Investigation,” says Christian P. Larsen, MD, DPhil, dean of the Emory University School of Medicine and fellow ASCI member.
“Their election into this respected and renowned society is a validation that the work they are contributing is impactful and they are among the nation’s leading biomedical investigators.”
The ASCI considers the nominations of several hundred physician-scientists submitted from among its members each year and elects up to 80 new members for their significant research accomplishments. Because members must be 50 years of age or younger at the time of their election, membership reflects accomplishments by its members relatively early in their careers.
The new members were officially welcomed into the ASCI at its annual ASCI dinner and new member induction ceremony on April 25, 2014 in Chicago.
Young-sup Yoon, MD, PhD
Yoon’s research interests focus on developing a strategy for regenerating or repairing cardiovascular diseases using stem cells and tissue engineering. His lab has focused on generating stem or progenitor cells and developing various methods to differentiate these cells into endothelial cells and cardiomyocytes. He investigates their therapeutic utility in various cardiovascular diseases such as peripheral vascular ischemia, myocardial infarction, heart failure, lymphedema and diabetic neuropathy.